U.Ozel.Images/E+ by way of Getty Images Although different firms are poised to have GLP-1 receptor agonist medication for weight loss authorized, they don’t seem to be…
Year: 2024
ImmunoPrecise Antibodies (NASDAQ:IPA) obtained a written notification from Nasdaq, notifying them that they don’t adjust to the minimal bid worth requirement outlined within the Nasdaq Listing…
Dexcom (NASDAQ:DXCM) mentioned on Monday its over-the-counter glucose biosensor Stelo is now available for buy in the U.S. Stelo is designed to assist folks, 18 years…
JHVEPhoto BeiGene (NASDAQ:BGNE) has obtained FDA Fast Track Designation for its investigational cancer therapy. BGB-16673, an orally obtainable BTK-targeting chimeric degradation activation compound, gained fast track…
Eliem Therapeutics (NASDAQ:ELYM) has introduced the appointments of Brett Kaplan as COO and Nishi Rampal as Senior Vice President, Clinical Development. Most not too long ago,…
Regeneron Pharmaceuticals (NASDAQ:REGN) mentioned on Monday its bispecific antibody Ordspono (odronextamab) has been cleared by the European Commission for the therapy of relapsed/refractory follicular lymphoma and…
AdaptHealth appoints Barnhart as COO Source: Seekingalpha
Vericel (NASDAQ:VCEL) has introduced that the U.S. FDA has authorised a supplemental Biologics License Application increasing the MACI® label to incorporate arthroscopic supply of MACI to…
NRx Pharmaceuticals reports potential acquisition and financing agreements Source: Seekingalpha
BCFC/iStock Editorial through Getty Images McKesson (NYSE:MCK) stated it would acquire a controlling interest in Core Ventures for $2.49B in money. Core Ventures was established by…